Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M311120200 on February 26, 2004

J. Biol. Chem., Vol. 279, Issue 21, 22371-22376, May 21, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/21/22371    most recent
M311120200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Date, T.
Right arrow Articles by Wakita, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Date, T.
Right arrow Articles by Wakita, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Genotype 2a Hepatitis C Virus Subgenomic Replicon Can Replicate in HepG2 and IMY-N9 Cells*

Tomoko Date{ddagger}, Takanobu Kato{ddagger}§, Michiko Miyamoto{ddagger}, Zijiang Zhao{ddagger}, Kotaro Yasui{ddagger}, Masashi Mizokami§, and Takaji Wakita{ddagger}||

From the {ddagger}Department of Microbiology, Tokyo Metropolitan Institute for Neuroscience, Tokyo 183-8526, Japan, the §Department of Clinical Molecular Informative Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan, and the Institute of Virology, Chinese Academy of Preventive Medicine, Beijing 100052, People's Republic of China

A hepatitis C virus genotype 2a subgenomic replicon, JFH-1 replicon, was previously established using the consensus sequence of clone JFH-1 from a patient with fulminant hepatitis and, in a previous report, was indicated to replicate efficiently in Huh7. Here the replication of JFH-1 replicon was tested in HepG2, a human hepatocyte-derived cell line, and in IMY-N9, a cell line developed by fusing human hepatocytes and HepG2 cells. Following transfection with in vitro transcribed replicon RNA and selection by cultivation with G418, colonies formed in both cell lines although at efficiencies substantially lower than those of Huh7. The H2476L mutation identified in the Huh7 replicon in our previous study increased the colony formation efficiencies of the JFH-1 replicon in HepG2 and IMY-N9 cells. Higher amounts of replicon RNA were detected in IMY-N9 clones than in HepG2 clones by real time detection reverse transcription-PCR, and replicon RNA replication and viral protein expression were confirmed by Northern and Western blotting in isolated clones. Sequencing of replicon RNAs revealed that mutations found in hepatitis C virus-derived regions were not identical and that two of nine HepG2 clones and three of nine IMY-N9 clones had no or one synonymous mutation. This system with the JFH-1 replicon and three cell lines is useful not only for estimating the cellular factors affecting viral activity but also for clarifying the common gene response of the host.


Received for publication, October 9, 2003 , and in revised form, February 19, 2004.

* This work was supported in part by a grant-in-aid for Scientific Research from the Japan Society for the Promotion of Science and the Ministry of Health, Labour, and Welfare of Japan, by a grant from Toray Industries, Inc., and by the Program for Promotion of Fundamental Studies in Health Sciences of the Organization for Pharmaceutical Safety and Research of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: Dept. of Microbiology, Tokyo Metropolitan Institute for Neuroscience, 2-6 Musashidai, Fuchu, Tokyo 183-8526, Japan. Tel.: 81-423-25-3881; Fax: 81-423-21-8678; E-mail: wakita{at}tmin.ac.jp.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
C. J. Mee, H. J. Harris, M. J. Farquhar, G. Wilson, G. Reynolds, C. Davis, S. C. D. van IJzendoorn, P. Balfe, and J. A. McKeating
Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells
J. Virol., June 15, 2009; 83(12): 6211 - 6221.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
R. Adair, A. H. Patel, L. Corless, S. Griffin, D. J. Rowlands, and C. J. McCormick
Expression of hepatitis C virus (HCV) structural proteins in trans facilitates encapsidation and transmission of HCV subgenomic RNA
J. Gen. Virol., April 1, 2009; 90(4): 833 - 842.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Chang, J.-T. Guo, D. Jiang, H. Guo, J. M. Taylor, and T. M. Block
Liver-Specific MicroRNA miR-122 Enhances the Replication of Hepatitis C Virus in Nonhepatic Cells
J. Virol., August 15, 2008; 82(16): 8215 - 8223.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. L. Tellinghuisen, M. J. Evans, T. von Hahn, S. You, and C. M. Rice
Studying Hepatitis C Virus: Making the Best of a Bad Virus
J. Virol., September 1, 2007; 81(17): 8853 - 8867.
[Full Text] [PDF]


Home page
J. Virol.Home page
T. Kato, T. Matsumura, T. Heller, S. Saito, R. K. Sapp, K. Murthy, T. Wakita, and T. J. Liang
Production of Infectious Hepatitis C Virus of Various Genotypes in Cell Cultures
J. Virol., May 1, 2007; 81(9): 4405 - 4411.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. A. Lazaro, M. Chang, W. Tang, J. Campbell, D. G. Sullivan, D. R. Gretch, L. Corey, R. W. Coombs, and N. Fausto
Hepatitis C Virus Replication in Transfected and Serum-Infected Cultured Human Fetal Hepatocytes
Am. J. Pathol., February 1, 2007; 170(2): 478 - 489.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. Koutsoudakis, E. Herrmann, S. Kallis, R. Bartenschlager, and T. Pietschmann
The Level of CD81 Cell Surface Expression Is a Key Determinant for Productive Entry of Hepatitis C Virus into Host Cells
J. Virol., January 15, 2007; 81(2): 588 - 598.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. B. Kapadia, H. Barth, T. Baumert, J. A. McKeating, and F. V. Chisari
Initiation of Hepatitis C Virus Infection Is Dependent on Cholesterol and Cooperativity between CD81 and Scavenger Receptor B Type I
J. Virol., January 1, 2007; 81(1): 374 - 383.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
T. Kato, T. Date, M. Miyamoto, M. Sugiyama, Y. Tanaka, E. Orito, T. Ohno, K. Sugihara, I. Hasegawa, K. Fujiwara, et al.
Detection of Anti-Hepatitis C Virus Effects of Interferon and Ribavirin by a Sensitive Replicon System
J. Clin. Microbiol., November 1, 2005; 43(11): 5679 - 5684.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
P. Targett-Adams and J. McLauchlan
Development and characterization of a transient-replication assay for the genotype 2a hepatitis C virus subgenomic replicon
J. Gen. Virol., November 1, 2005; 86(11): 3075 - 3080.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. P. Windisch, M. Frese, A. Kaul, M. Trippler, V. Lohmann, and R. Bartenschlager
Dissecting the Interferon-Induced Inhibition of Hepatitis C Virus Replication by Using a Novel Host Cell Line
J. Virol., November 1, 2005; 79(21): 13778 - 13793.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
B. D. Lindenbach, M. J. Evans, A. J. Syder, B. Wolk, T. L. Tellinghuisen, C. C. Liu, T. Maruyama, R. O. Hynes, D. R. Burton, J. A. McKeating, et al.
Complete Replication of Hepatitis C Virus in Cell Culture
Science, July 22, 2005; 309(5734): 623 - 626.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Zhong, P. Gastaminza, G. Cheng, S. Kapadia, T. Kato, D. R. Burton, S. F. Wieland, S. L. Uprichard, T. Wakita, and F. V. Chisari
Robust hepatitis C virus infection in vitro
PNAS, June 28, 2005; 102(26): 9294 - 9299.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Kato, T. Date, M. Miyamoto, Z. Zhao, M. Mizokami, and T. Wakita
Nonhepatic Cell Lines HeLa and 293 Support Efficient Replication of the Hepatitis C Virus Genotype 2a Subgenomic Replicon
J. Virol., January 1, 2005; 79(1): 592 - 596.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. Kanazawa, M. Kurosaki, N. Sakamoto, N. Enomoto, Y. Itsui, T. Yamashiro, Y. Tanabe, S. Maekawa, M. Nakagawa, C.-H. Chen, et al.
Regulation of Hepatitis C Virus Replication by Interferon Regulatory Factor 1
J. Virol., September 15, 2004; 78(18): 9713 - 9720.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement